Английская Википедия:ADX-71149

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Drugbox

ADX-71149, also known as JNJ-40411813 and JNJ-mGluR2-PAM, is a selective positive allosteric modulator of the mGlu2 receptor.[1][2][3] It is being studied by Addex Therapeutics and Janssen Pharmaceuticals for the treatment of schizophrenia.[4] It was also researched by these companies for the treatment of anxious depression (major depressive disorder with anxiety symptoms),[5] but although some efficacy was observed in clinical trials, it was not enough to warrant further development for this indication.[6] Шаблон:As of, ADX-71149 is in phase II clinical trials for schizophrenia.[4]

See also

References

Шаблон:Reflist

External links

Шаблон:Metabotropic glutamate receptor modulators Шаблон:Nervous-system-drug-stub